CCL11-induced eosinophils inhibit the formation of blood vessels and cause tumor necrosis

Genes to Cells

Volumn 21, Issue 6, 2016, Pages 624-638

  Xing, Yanjiang ^a   Tian, Yijun ^a   Kurosawa, Takamasa ^a   Matsui, Sayaka ^a   Touma, Maki ^a   Yanai, Takanori ^b   Wu, Qiong ^c   Sugimoto, Kenkichi ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b INSTITUTE FOR ENVIRONMENTAL SCIENCES   (Japan)

^c HARBIN INSTITUTE OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL INFILTRATION; CELL MIGRATION; CONTROLLED STUDY; DISEASE ACTIVITY; EOSINOPHIL; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR CLONING; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

EID: 84974695808     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/gtc.12371     Document Type: Article

References (52)

1. Asai, T., Ueda, T., Itoh, K., Yoshioka, K., Aoki, Y., Mori, S. & Yoshikawa, H. (1998) Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung. Int. J. Cancer 76, 418–422.
2. Bettigole, S.E., Lis, R., Adoro, S., Lee, A.-H., Spencer, L.A., Weller, P.F. & Glimcher, L.H. (2015) The transcription factor XBP1 is selectively required for eosinophil differentiation. Nat. Immunol. 16, 829–837.
3. Bochner, B.S. (2009) Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors. Clin. Exp. Allergy 39, 317–324.
4. Dealtry, G., Naylor, M., Fiers, W. & Balkwill, F. (1987) The effect of recombinant human tumour necrosis factor on growth and macromolecular synthesis of human epithelial cells. Exp. Cell Res. 170, 428–438.
5. Di Carlo, E., Forni, G., Lollini, P., Colombo, M.P., Modesti, A. & Musiani, P. (2001) The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 97, 339–345.
6. Epstein, A.C., Gleadle, J.M., McNeill, L.A., Hewitson, K.S., O'Rourke, J., Mole, D.R., Mukherji, M., Metzen, E., Wilson, M.I. & Dhanda, A. (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43–54.
7. Erez, N., Milyavsky, M., Eilam, R., Shats, I., Goldfinger, N. & Rotter, V. (2003) Expression of prolyl-hydroxylase-1 (PHD1/EGLN2) suppresses hypoxia inducible factor-1α activation and inhibits tumor growth. Cancer Res. 63, 8777–8783.
8. Falkencrone, S., Poulsen, L.K., Bindslev-Jensen, C., Woetmann, A., Odum, N., Poulsen, B.C., Blom, L., Jensen, B., Gibbs, B. & Yasinska, I. (2013) IgE-mediated basophil tumour necrosis factor alpha induces matrix metalloproteinase-9 from monocytes. Allergy 68, 614–620.
9. Foekens, J.A., Ries, C., Look, M.P., Gippner-Steppert, C., Klijn, J.G. & Jochum, M. (2003) The prognostic value of polymorphonuclear leukocyte elastase in patients with primary breast cancer. Cancer Res. 63, 337–341.
10. Fridlender, Z.G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G.S. & Albelda, S.M. (2009) Polarization of tumor-associated neutrophil phenotype by TGF-β:”N1” versus “N2” TAN. Cancer Cell 16, 183–194.
11. Haranaka, K., Satomi, N. & Sakurai, A. (1984) Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice. Int. J. Cancer 34, 263–267.
12. Henan, X., Toyota, N., Yanjiang, X., Fujita, Y., Zhijun, H., Touma, M., Qiong, W. & Sugimoto, K. (2014) Enhancement of phagocytosis and cytotoxicity in macrophages by tumor-derived IL-18 stimulation. BMB Rep. 47, 286–291.
13. Huaux, F., Gharaee-Kermani, M., Liu, T., Morel, V., McGarry, B., Ullenbruch, M., Kunkel, S.L., Wang, J., Xing, Z. & Phan, S.H. (2005) Role of Eotaxin-1 (CCL11) and CC chemokine receptor 3 (CCR3) in bleomycin-induced lung injury and fibrosis. Am. J. Pathol. 167, 1485–1496.
14. Jablonska, J., Leschner, S., Westphal, K., Lienenklaus, S. & Weiss, S. (2010) Neutrophils responsive to endogenous IFN-β regulate tumor angiogenesis and growth in a mouse tumor model. J. Clin. Investig. 120, 1151.
15. Jose, P., Griffiths-Johnson, D., Collins, P., Walsh, D., Moqbel, R., Totty, N., Truong, O., Hsuan, J. & Williams, T. (1994) Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. 179, 881–887.
16. Kitaura, M., Nakajima, T., Imai, T., Harada, S., Combadiere, C., Tiffany, H.L., Murphy, P.M. & Yoshie, O. (1996) Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J. Biol. Chem. 271, 7725–7730.
17. Koshiba, T., Hosotani, R., Wada, M., Miyamoto, Y., Fujimoto, K., Lee, J.U., Arii, S. & Imamura, M. (1998) Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma. Cancer 82, 642–650.
18. Lamkhioued, B., Abdelilah, S.G., Hamid, Q., Mansour, N., Delespesse, G. & Renzi, P.M. (2003) The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34 + progenitor cells. J. Immunol. 170, 537–547.
19. Lawrence, T. & Natoli, G. (2011) Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11, 750–761.
20. Levina, V., Nolen, B.M., Marrangoni, A.M., Cheng, P., Marks, J.R., Szczepanski, M.J., Szajnik, M.E., Gorelik, E. & Lokshin, A.E. (2009) Role of eotaxin-1 signaling in ovarian cancer. Clin. Cancer Res. 15, 2647–2656.
21. Li, D., Beisswenger, C., Herr, C., Schmid, R., Gallo, R., Han, G., Zakharkina, T. & Bals, R. (2014) Expression of the antimicrobial peptide cathelicidin in myeloid cells is required for lung tumor growth. Oncogene 33, 2709–2716.
22. Lopez, A.F., Begley, C.G., Williamson, D.J., Warren, D.J., Vadas, M.A. & Sanderson, C.J. (1986) Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells. J. Exp. Med. 163, 1085–1099.
23. Lungarella, G., Menegazzi, R., Gardi, C., Spessotto, P., de Santi, M.M., Bertoncin, P., Patriarca, P., Calzoni, P. & Zabucchi, G. (1992) Identification of elastase in human eosinophils: immunolocalization, isolation, and partial characterization. Arch. Biochem. Biophys. 292, 128–135.
24. MacPherson, J.C., Comhair, S.A., Erzurum, S.C., Klein, D.F., Lipscomb, M.F., Kavuru, M.S., Samoszuk, M.K. & Hazen, S.L. (2001) Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species. J. Immunol. 166, 5763–5772.
25. Martinez, F.O. & Gordon, S. (2014) The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000prime Rep. 6, 13.
26. Martinez, F.O., Sica, A., Mantovani, A. & Locati, M. (2007) Macrophage activation and polarization. Front Biosci. 13, 453–461.
27. Mishalian, I., Bayuh, R., Levy, L., Zolotarov, L., Michaeli, J. & Fridlender, Z.G. (2013) Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression. Cancer Immunol. Immunother. 62, 1745–1756.
28. Motoo, Y., Hill, N., Mahmoudi, M. & Osther, K. (1986) Antitumor effect of human necrosis factor on human hepatoma cells PLC/PRF/5. Jpn. J. Exp. Med. 56, 151–154.
29. Okada, S., Kita, H., George, T.J., Gleich, G.J. & Leiferman, K.M. (1997) Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am. J. Respir. Cell Mol. Biol. 17, 519–528.
30. de Paulis, A., Prevete, N., Fiorentino, I., Rossi, F.W., Staibano, S., Montuori, N., Ragno, P., Longobardi, A., Liccardo, B. & Genovese, A. (2006) Expression and functions of the vascular endothelial growth factors and their receptors in human basophils. J. Immunol. 177, 7322–7331.
31. Pekarek, L.A., Starr, B.A., Toledano, A.Y. & Schreiber, H. (1995) Inhibition of tumor growth by elimination of granulocytes. J. Exp. Med. 181, 435–440.
32. Ponath, P.D., Qin, S., Post, T.W., Wang, J., Wu, L., Gerard, N.P., Newman, W., Gerard, C. & Mackay, C.R. (1996) Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J. Exp. Med. 183, 2437–2448.
33. Puxeddu, I., Alian, A., Piliponsky, A.M., Ribatti, D., Panet, A. & Levi-Schaffer, F. (2005) Human peripheral blood eosinophils induce angiogenesis. Int. J. Biochem. Cell Biol. 37, 628–636.
34. Quail, D.F. & Joyce, J.A. (2013) Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423–1437.
35. Rankin, S.M., Conroy, D.M. & Williams, T.J. (2000) Eotaxin and eosinophil recruitment: implications for human disease. Mol. Med. Today 6, 20–27.
36. Rothenberg, M.E. & Hogan, S.P. (2006) The eosinophil. Immunology 24, 147.
37. Sharma, J., Al-Omran, A. & Parvathy, S. (2007) Role of nitric oxide in inflammatory diseases. Inflammopharmacology 15, 252–259.
38. Shojaei, F., Singh, M., Thompson, J.D. & Ferrara, N. (2008) Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression. Proc. Natl Acad. Sci. USA 105, 2640–2645.
39. Simson, L., Ellyard, J.I., Dent, L.A., Matthaei, K.I., Rothenberg, M.E., Foster, P.S., Smyth, M.J. & Parish, C.R. (2007) Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance. J. Immunol. 178, 4222–4229.
40. Slifman, N., Loegering, D., McKean, D. & Gleich, G.J. (1986) Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein. J. Immunol. 137, 2913–2917.
41. Sonoda, Y., Arai, N. & Ogawa, M. (1989) Humoral regulation of eosinophilopoiesis in vitro: analysis of the targets of interleukin-3, granulocyte/macrophage colony-stimulating factor (GM-CSF), and interleukin-5. Leukemia 3, 14–18.
42. Stevenson, N.J., Addley, M.R., Ryan, E.J., Boyd, C.R., Carroll, H.P., Paunovic, V., Bursill, C.A., Miller, H.C., Channon, K.M. & McClurg, A.E. (2009) CCL11 blocks IL-4 and GM-CSF signaling in hematopoietic cells and hinders dendritic cell differentiation via suppressor of cytokine signaling expression. J. Leukoc. Biol. 85, 289–297.
43. Sugimoto, K., Yoshida, S., Mashio, Y., Toyota, N., Xing, Y., Xu, H., Fujita, Y., Huang, Z., Touma, M. & Wu, Q. (2014) Role of FGF10 on tumorigenesis by MS-K. Genes Cells 19, 112–125.
44. Tazawa, H., Okada, F., Kobayashi, T., Tada, M., Mori, Y., Une, Y., Sendo, F., Kobayashi, M. & Hosokawa, M. (2003) Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression. Am. J. Pathol. 163, 2221–2232.
45. Tepper, R.I., Coffman, R.L. & Leder, P. (1992) An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 257, 548–551.
46. To, K.K. & Huang, L.E. (2005) Suppression of hypoxia-inducible factor 1α (HIF-1α) transcriptional activity by the HIF prolyl hydroxylase EGLN1. J. Biol. Chem. 280, 38102–38107.
47. Villeda, S.A., Luo, J., Mosher, K.I., Zou, B., Britschgi, M., Bieri, G., Stan, T.M., Fainberg, N., Ding, Z. & Eggel, A. (2011) The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477, 90–94.
48. Voehringer, D., Van Rooijen, N. & Locksley, R.M. (2007) Eosinophils develop in distinct stages and are recruited to peripheral sites by alternatively activated macrophages. J. Leukoc. Biol. 81, 1434–1444.
49. Wels, J., Kaplan, R.N., Rafii, S. & Lyden, D. (2008) Migratory neighbors and distant invaders: tumor-associated niche cells. Genes Dev. 22, 559–574.
50. Xie, F., Liu, L.-B., Shang, W.-Q., Chang, K.-K., Meng, Y.-H., Mei, J., Yu, J.-J., Li, D.-J. & Li, M.-Q. (2015) The infiltration and functional regulation of eosinophils induced by TSLP promote the proliferation of cervical cancer cell. Cancer Lett. 364, 106–117.
51. Xing, Y., Tian, Y., Kurosawa, T., Matsui, S., Touma, M., Wu, Q. & Sugimoto, K. (2016) Inhibition of blood vessel formation in tumors by IL-18-polarized M1 macrophages. Genes Cells 21, 287–295.
52. Zhu, X.-Q., Lv, J.-Q., Lin, Y., Xiang, M., Gao, B.-H. & Shi, Y.-F. (2007) Expression of chemokines CCL5 and CCL11 by smooth muscle tumor cells of the uterus and its possible role in the recruitment of mast cells. Gynecol. Oncol. 105, 650–656.